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virus persistence, and flaviviral
recombination as a mechanism of fla-
viviral evolution. In addition, data
were presented that illustrated the per-
sistence of, and immune modulation
by, alphaviruses, which, in concert,
allow the virus to replicate while pre-
venting the host from responding to
its benefit.
Other than the classical techniques
of preventing infection, little was
mentioned about disease control dur-
ing this symposium. Control must be
based on rapid recognition of early
cases, subsequent immunization of
persons or animals at risk, or immu-
nization of persons or animals with the
potential to be at risk, such as travel-
ers, laboratory personnel, and attend-
ing clinicians. Attendees learned about
diverse methods being used to develop
vaccines. Representatives from the
World Health Organization explained
that organization’s plans for respond-
ing to disease emergence and for pre-
venting zoonotic diseases from reach-
ing human populations.
New paradigms for field studies of
zoonotic diseases are necessary.
These approaches must include longi-
tudinal and in-depth investigations of
agent, host, habitat, and environment
if we are to predict risk and respond in
an appropriate manner. At this time,
zoonotic disease control comprises
prevention and public education and
not much more. Progress is being
made in rapid diagnosis, production
of sophisticated vaccines, and under-
standing of the molecular mecha-
nisms by which zoonotic viruses per-
sist and cause disease.
Most of the papers presented will
be published in a special issue of
Archives of Virology.
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Conference Summary
New and
Reemerging
Infectious Diseases
The Sixth Annual Conference on
New and Reemerging Infectious
Diseases was hosted April 24–25,
2003, by the Center for Zoonoses
Research and the College of
Veterinary Medicine, University of
Illinois at Urbana-Champaign
(UIUC). The conference featured
seven speakers and 27 poster presen-
tations.
Smallpox
Bertram L. Jacobs (Arizona State
University, Tempe, AZ) opened the
conference with a presentation on
smallpox, one of the most devastating
diseases known to humankind.
Smallpox was eradicated from the
wild in the 1970s, although the poten-
tial use of Variola virus as a bioterror-
ism agent makes it still of great con-
cern. Dr. Jacobs described Vaccinia
viruses deficient in E3L, a regulator
of the cellular antiviral response and
noted their potential for the produc-
tion of improved vaccines. He also
showed that double-stranded
(ds)RNA- and ZDNA binding pro-
teins had a role in poxvirus pathogen-
esis. In the poster section, Joanna
Shisler (University of Illinois at
Urbana-Champaign [UIUC], Urbana)
reported that the modified virus,
Ankara, activates nuclear factor κB
through the mitogen-activated protein
kinase, extracellular signal–regulated
kinase (MEK)/ERK extracellular sig-
nal–regulated kinase (ERK) pathway,
possibly facilitating the host immune
response. This virus was used to vac-
cinate 100,000 people, with no report-
ed complications, at the end of the
global smallpox vaccination cam-
paign led by the World Health
Organization in the 1970s.
West Nile Virus and Geographic
Information Systems
Since it was first detected in New
York City in 1999, West Nile virus
(WNV) has spread from coast to coast
and has been found in 43 states from
Maine to California. Stephen C.
Guptill (U.S. Geological Survey,
Reston, VA) reported that the U.S.
Geological Survey is working with
the Centers for Disease Control and
Prevention (CDC) to learn the current
geographic extent of WNV. This will
allow us to understand how it moves
between birds, mosquitoes, and
humans and to better predict future
outbreaks. A collaborative 3-year
research project is being conducted on
lands administered by the U.S. Fish
and Wildlife Service, the National
Park Service, and other federal lands,
and on state, local, and private lands
along the Atlantic and Mississippi fly-
ways. This study tests sampled migra-
tory and local wild birds to detect
WNV and identify possible avian car-
riers. Over 10,000 birds of more than
150 species have been captured, sam-
pled, and released at 20 federal sites
and 3 other sites in 12 states during
the spring and fall bird migration sea-
sons of 2001 and 2002. A parallel
study, conducted with CDC, is exam-
ining the distribution and number of
mosquito species in relation to land
cover, weather conditions, and avian
deaths. Systematic mosquito surveil-
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sites) is being conducted year-round
in St. Tammany Parish in Louisiana,
complementing avian collections at
the Bogue Chitto and Big Branch
National Wildlife Refuges in the
parish. Finally, WNV surveillance
data from CDC is being studied to
determine the spatial and temporal
relationships between disease out-
breaks in birds and animals and
human illness. Information from these
analyses will guide the creation of
predictive models of disease risk.
These surveillance systems provide
the basic information on the “geogra-
phy” of the virus. Combining these
data with information about avian
migratory patterns, landscape charac-
teristics, and weather conditions, over
space and time, will provide the foun-
dation for developing spatial analyti-
cal and forecasting models to assess
the risk for human illness. In related
work, presented at the poster session,
Marylin Ruiz (UIUC, Urbana) report-
ed the efforts of the College of
Veterinary Medicine Geographic
Information System and Spatial
Analysis Laboratory, in collaboration
with the Illinois Department of Public
Health, and the Illinois Department of
Agriculture in the mapping and analy-
sis of the WNV outbreak in Illinois.
(Illinois was the state hit the hardest
by the epidemic in 2002.) Geographic
information systems in conjunction
with fine resolution satellite data and
spatial statistics are also useful to
investigate the distribution of other
diseases, for example, schistosomiasis
(Julie A. Clennon, UIUC, Urbana).
Animal Models of Infectious
Diseases
Streptococcal pathogens continue
to evade concerted efforts to decipher
clear-cut virulence mechanisms,
although numerous genes have been
implicated in pathogenesis. Melody
N. Neely (Wayne State University,
Detroit, MI) reported the development
of a unique animal model, the
zebrafish (Danio rerio), to character-
ize specific virulence mechanisms
used within various tissues in vivo.
Her group is using this model host to
study infection by two streptococcal
species that represent two forms of
streptococcal disease: a natural
pathogen of fish and humans,
Streptococcus initiae, and a human-
specific pathogen, S. pyogenes. S. ini-
tiae primarily causes a fatal systemic
disease in the zebrafish after intra-
muscular injection, with pathologic
changes similar to those seen in
human infections caused by S.
agalactiae  and  S. pneumoniae. The
fatal infection by S. pyogenes causes a
locally spreading necrotic disease
confined to the muscle with patholog-
ic features similar to those observed in
a human infection of necrotizing
fasciitis. By studying pathogens that
are virulent for both fish and humans
and that mediate disease states in the
zebrafish identical to those found in
human streptococcal infections, com-
mon virulence strategies shared by a
number of gram-positive pathogens
can be identified. Using several genet-
ic strategies with the two streptococ-
cal strains, Dr. Neely’s group is cur-
rently conducting specific screens in
the zebrafish to 1) identify and char-
acterize cell membrane proteins that
interact with the host in vivo to cause
specific disease states; 2) identify
genes required for growth in vivo, as
well as progressive stages of infec-
tion; 3) identify genes that are only
expressed while in the host along with
tissue specificity of the encoded pro-
teins; and 4) analyze responses of the
host that affect progression of disease.
Foodborne Diseases
Shigella boydii is a food pathogen
that was implicated in a 1999 food-
borne outbreak involving contaminat-
ed bean salad that contained fresh
parsley and cilantro. Hans Blaschek
and collaborators (UIUC, Urbana)
reported the high tolerance of this
bacterium to acidic pH, and the pres-
ence and formation of biofilms in
cilantro and parsley samples treated
with produce wash and water. Cells in
biofilms are known to be more resist-
ant to antibiotics and disinfectants,
and biofilm formation may explain
the decreased efficacy of produce
wash on parsley and cilantro samples.
Intracellular Parasites
The trypanosomatid protozoan
Leishmania  synthesizes a variety of
glycosylphosphatidylinositol (GPI
GPI)-anchored molecules on its sur-
face. Sorting out their individual func-
tions has been difficult and in some
cases controversial as they share
structural domains and generally have
been tested outside the context of key
components such as the major glycol-
ipid lipohosphoglycan (LPG) and
phosphoglycans (PGs); ether lipids,
which constitute approximately 20%
of the membrane lipids and most GPI
anchors; and others. Stephen M.
Beverley and his collaborators
(Washington University, St. Louis,
MO) have studied their role in the
context of parasite knockouts and
“add-back” controls, probing their
role in diverse aspects of parasitism
such as entry, inhibition of phagolyso-
somal fusion and host-signal trans-
duction, and pathogenesis. All of
these molecules play critical roles in
virulence, although sometimes in
unanticipated ways. PGs in particular
are required for parasite persistence
but not acute pathology, therefore
defining a new class of parasite genes
important to transmission. Ted
Hackstadt (National Institute of
Allergy and Infectious Diseases,
National Institutes of Health,
Hamilton, MT) reported that, unlike
the majority of most intracellular par-
asites, which block maturation of
endosomes to lysosomes at discrete
stages and then replicate within those
vacuoles, chlamydiae appear to disso-
ciate themselves from the endocytic
pathway shortly after internalization
by actively modifying the vacuole to
become fusogenic with sphin-1032 Emerging Infectious Diseases • Vol. 9, No. 8, August 2003
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gomyelin-containing exocytic vesi-
cles. Interaction with a secretory path-
way appears to provide a pathogenic
mechanism that allows chlamydiae to
establish themselves in a site not des-
tined to fuse with lysosomes. Fusion
with Golgi-derived vesicles provides
a likely source of cellular lipids for
the growth of the inclusion membrane
as it expands to accommodate the
multiplying parasites. 
Kasturi Haldar (Northwestern
University, Chicago, IL) presented
studies on the malaria parasite, focus-
ing on protein trafficking, gene
expression, and drug development.
Her group has studied vacuolar traf-
ficking of host raft proteins and para-
site virulence determinants (by tag-
ging genes with GFP and expressing
them by transfection) for their conse-
quences on malarial entry into the red
blood cell, virulence secretion sys-
tems, and apicoplast biogenesis. The
apicoplast is a newly identified resid-
ual plastid acquired by secondary
endosymbiosis that has attracted
attention for its evolutionary novelty
and its potential as a drug target.
Temporal regulation of plasmodial
genes may be important for protein-
targeting in cells. In this context, Dr.
Haldar’s group is examining the role
of unique promoter elements and
chromatin in regulating expression of
secretory determinants such as the
histidine-rich proteins and adherence
antigens. Whole genome scanning
approaches (microarrays and other
functional approaches) are being used
in combination with informatics to
develop novel lipid-linked targets for
drug development. Studies on
Salmonella  are currently examining
effectors of the SPI-2 system
(Salmonella  Pathogenicity Island–2
system) for their effects on sterol
recruitment, metabolism, and bacteri-
al virulence in the mouse model. The
requirement for nonsterol precursors
in protecting infected cells from death
by apoptotis, necrosis, or both, is also
being investigated. Finally, microar-
rays are used to identify subsets of S.
typhimurium  virulence determinants
required for lipid-linked intracellular
bacterial replication. 
Toxoplasma gondii is a major
cause of birth defects and infections in
immunocompromised persons. Like
all members of the phylum
Apicomplexa, T. gondii is an obligate
intracellular organism. Micronemes
and rhoptries are specialized secretory
organelles of the Apicomplexa, whose
contents are thought to be essential for
successful invasion of host cells.
Kami Kim (Albert Einstein College of
Medicine, Bronx, NY) reported iden-
tifying two subtilisin-like serine pro-
teinases from T. gondii, TgSUB1 and
TgSUB2, which are necessary for
successful invasion. Serine proteinase
inhibitors have been reported to block
host cell invasion by both T. gondii
and the related apicomplexan parasite,
P. falciparum. Disruption of TgSUB2
was unsuccessful, which implies that
TgSUB2  is an essential gene. Both
TgSUB1 and TgSUB2 undergo auto-
catalytic processing as they traffic
through the secretory pathway.
TgSUB1 is a microneme protein,
whereas TgSUB2 localizes to rhop-
tries and associates with rhoptry pro-
tein ROP1, a potential substrate.
Mutational analysis suggests that
TgSUB2 is a rhoptry protein mat-
urase. Processing of secretory
organelle contents appears to be ubiq-
uitous among the Apicomplexa. Since
subtilases are found in genomes of all
the Apicomplexa sequenced to date,
they may represent a novel
chemotherapeutic target. Transcrip-
tional regulatory pathways in apicom-
plexan parasites are understudied and
may contain novel drug targets.
William Sullivan and his collabora-
tors (Indiana University School of
Medicine, Indianapolis, IN) identified
and mapped a gene in T. gondii that
encodes a homologue of chromatin
remodeling factors that uses ATP to
promote a more favorable environ-
ment for transcription. They also
described a novel histone acetyltrans-
ferase, which contains a unique 820-
amino acid N-terminal extension of
unknown function.
Parasite Organelles
Acidocalcisomes are novel calci-
um-containing acidic organelles pres-
ent in unicellular eukaryotes. Several
posters from researchers in the groups
of Silvia Moreno and Roberto
Docampo (UIUC, Urbana) highlight-
ed recent work on these organelles.
Andrea Montalvetti described a func-
tional aquaporin (water channel)
found in the organelles of T. cruzi, the
etiologic agent of Chagas disease, and
Peter Rohloff showed that this protein
is translocated to the contractile vac-
uole upon hypo-osmotic stress.
Joanna Cox and Shuhong Luo demon-
strated that a Ca
2+-ATPase is localized
to acidocalcisomes and the plasma
membrane of Trypanosoma brucei,
the etiologic agent of African sleeping
sickness, and is essential for cell
growth, as demonstrated by RNA
interference experiments. Manfredo
Seufferheld presented evidence of the
presence acidocalcisomes in the bac-
terium  Rodospirillum rubrum. Felix
Ruiz showed that acidocalcisomes of
Plasmodium falciparum, one of the
etiologic agents of malaria, do not dif-
fer significantly from the organelles in
other apicomplexan parasites, where-
as the platelet-dense granules possess
several characteristics common to aci-
docalcisomes. T. brucei possesses a P-
type proton ATPase with homology to
fungal and plant H+-ATPases but
absent in mammalian cells; this pro-
ton  constitutes a formidable target for
chemotherapy (Shuhong Luo, UIUC,
Urbana). 
Chemotherapeutic Targets
A number of poster presentations
identified novel chemotherapeutic tar-
gets for infectious diseases. Steve
Grimme (UIUC, Urbana), who
received an award for the best poster
presentation, demonstrated that a GPIEmerging Infectious Diseases • Vol. 9, No. 8, August 2003 1033
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mannosyltransferase (CaSMP3) was
essential for the human pathogenic
fungus  Candida albicans and there-
fore was validated as a potential target
for chemotherapy. M. Laura Salto
(UIUC, Urbana) showed that inosi-
tolphosphoceramide, a lipid used in
anchoring several proteins to the plas-
ma membrane of T. cruzi and absent
in the host, is remodeled during the
differentiation of different stages of
the parasite. Novel lipid modified
phosphoinositide phospholipases C
were reported in T. cruzi (Michael
Okura, UIUC, Urbana) and T. brucei
(Jianmin Fang, UIUC, Urbana). The
enzymes are apparently involved in
differentiation of the parasites and are
different from their host counterparts.
Recently, bisphosphonates have been
proposed as novel antiparasitic drugs,
and Yan Ling (UIUC, Urbana) report-
ed the cloning and characterization of
Toxoplasma gondii farnesyl
pyrophosphate synthase, the target of
these compounds. Tryptophan metab-
olism in mosquitoes and the separa-
tion and identification of mosquito
chrorion proteins through two-dimen-
sional electrophoresis and mass spec-
trometry will provide useful targets
against these vectors of several infec-
tious diseases, as reported by
Jianyong Li and his collaborators
(UIUC, Urbana). 
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The Yellow Book
The Division of Global Migration and Quarantine, National Center for Infectious Diseases, Centers for Disease
Control and Prevention, announces the availability of the 2003-2004 edition of Health Information for
International Travel (The Yellow Book). Features of this edition include new recommendations for malaria
chemoprophylaxis; updated, expanded sections on injury during travel, motion sickness, altitude sickness, and
travelers with disabilities; revised vaccine recommendations; changes in recommendations for insect repel-
lents; a new chapter focusing on recommendations for children; new text on scuba diving safety and high-risk
travelers; and improved maps and indexing.
The Yellow Book will also be available on CD-ROM later in the year. To order the book or the CD-ROM,
contact the Public Health Foundation at 1-877-252-1200 or http://bookstore.phf.org.